Efficacy and Safety of Everolimus in Liver Transplant Recipients of Living Donor Liver Transplants
Clinical trial NCT01888432 · COMPLETED
Trial details
- NCT number
- NCT01888432
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-25
- Primary completion
- 2016-10-19
- Enrollment
- 285
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.